This article is part of the supplement: The evolution of anti-TNF therapy in rheumatic disease: experience, insights and advances

Email this article to a friend

Anti-TNF therapy: what have we learned in 12 years?

Joachim R Kalden

Arthritis Research & Therapy 2011, 13(Suppl 1):S1 doi:10.1186/1478-6354-13-S1-S1

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive Arthritis Research & Therapy's emails?